245 related articles for article (PubMed ID: 18849282)
1. Review. The neuropathology of kuru and variant Creutzfeldt-Jakob disease.
McLean CA
Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3685-7. PubMed ID: 18849282
[TBL] [Abstract][Full Text] [Related]
2. Comparative neuropathology of Kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host.
McLean CA; Ironside JW; Alpers MP; Brown PW; Cervenakova L; Anderson RM; Masters CL
Brain Pathol; 1998 Jul; 8(3):429-37. PubMed ID: 9669694
[TBL] [Abstract][Full Text] [Related]
3. Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease.
Cervenáková L; Goldfarb LG; Garruto R; Lee HS; Gajdusek DC; Brown P
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13239-41. PubMed ID: 9789072
[TBL] [Abstract][Full Text] [Related]
4. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P
Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649
[TBL] [Abstract][Full Text] [Related]
6. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
[TBL] [Abstract][Full Text] [Related]
7. Creutzfeldt-Jakob disease with long duration and panencephalopathic lesions: molecular analysis of one case.
Ghorayeb I; Series C; Parchi P; Sawan B; Guez S; Laplanche JL; Capellari S; Gambetti P; Vital C
Neurology; 1998 Jul; 51(1):271-4. PubMed ID: 9674819
[TBL] [Abstract][Full Text] [Related]
8. Creutzfeldt-Jakob disease patients with congophilic kuru plaques have the missense variant prion protein common to Gerstmann-Sträussler syndrome.
Doh-ura K; Tateishi J; Kitamoto T; Sasaki H; Sakaki Y
Ann Neurol; 1990 Feb; 27(2):121-6. PubMed ID: 2180366
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology of human prion diseases (spongiform encephalopathies).
Kretzschmar HA
Dev Biol Stand; 1993; 80():71-90. PubMed ID: 8270118
[TBL] [Abstract][Full Text] [Related]
10. A traceback phenomenon can reveal the origin of prion infection.
Kobayashi A; Asano M; Mohri S; Kitamoto T
Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
[TBL] [Abstract][Full Text] [Related]
11. Review. The origin of the prion agent of kuru: molecular and biological strain typing.
Wadsworth JD; Joiner S; Linehan JM; Asante EA; Brandner S; Collinge J
Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3747-53. PubMed ID: 18849291
[TBL] [Abstract][Full Text] [Related]
12. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type.
Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P
Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639
[TBL] [Abstract][Full Text] [Related]
13. Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease.
Brandner S; Whitfield J; Boone K; Puwa A; O'Malley C; Linehan JM; Joiner S; Scaravilli F; Calder I; P Alpers M; Wadsworth JD; Collinge J
Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3755-63. PubMed ID: 18849292
[TBL] [Abstract][Full Text] [Related]
14. Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.
Takeuchi A; Kobayashi A; Ironside JW; Mohri S; Kitamoto T
J Biol Chem; 2013 Jul; 288(30):21659-66. PubMed ID: 23792955
[TBL] [Abstract][Full Text] [Related]
15. [An autopsy-verified case of Creutzfeldt-Jakob disease with codon 129 polymorphism and codon 180 point mutation].
Matsumura T; Kojima S; Kuroiwa Y; Takagi A; Unakami M; Kitamoto T
Rinsho Shinkeigaku; 1995 Mar; 35(3):282-5. PubMed ID: 7614752
[TBL] [Abstract][Full Text] [Related]
16. Kuru: genes, cannibals and neuropathology.
Liberski PP; Sikorska B; Lindenbaum S; Goldfarb LG; McLean C; Hainfellner JA; Brown P
J Neuropathol Exp Neurol; 2012 Feb; 71(2):92-103. PubMed ID: 22249461
[TBL] [Abstract][Full Text] [Related]
17. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
Zaborowski A
Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
[TBL] [Abstract][Full Text] [Related]
18. Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes.
Diack AB; Boyle A; Plinston C; Hunt E; Bishop MT; Will RG; Manson JC
Brain; 2019 May; 142(5):1416-1428. PubMed ID: 30938429
[TBL] [Abstract][Full Text] [Related]
19. Autopsy case of Creutzfeldt-Jakob disease with Met/Val heterozygosity at codon 129 and type 1 protease-resistant prion protein presenting some florid-type plaques and many Kuru plaques in the cerebellum.
Kawauchi Y; Kamitani T; Yagishita S; Kitamoto T; Kishida H
Neuropathology; 2006 Aug; 26(4):313-7. PubMed ID: 16961067
[TBL] [Abstract][Full Text] [Related]
20. Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association study.
Mead S; Poulter M; Uphill J; Beck J; Whitfield J; Webb TE; Campbell T; Adamson G; Deriziotis P; Tabrizi SJ; Hummerich H; Verzilli C; Alpers MP; Whittaker JC; Collinge J
Lancet Neurol; 2009 Jan; 8(1):57-66. PubMed ID: 19081515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
